These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 28269782

  • 21. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
    Mohammadinasr M, Montazersaheb S, Molavi O, Kahroba H, Talebi M, Ayromlou H, Hejazi MS.
    Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
    [Abstract] [Full Text] [Related]

  • 22. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
    Dong Z, Gu H, Guo Q, Liang S, Xue J, Yao F, Liu X, Li F, Liu H, Sun L, Zhao K.
    Mol Neurobiol; 2021 Jul; 58(7):3084-3094. PubMed ID: 33629272
    [Abstract] [Full Text] [Related]

  • 23. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
    Li F, Xie XY, Sui XF, Wang P, Chen Z, Zhang JB.
    Neuroscience; 2020 Apr 15; 432():240-246. PubMed ID: 32135232
    [Abstract] [Full Text] [Related]

  • 24. Upregulated Blood miR-150-5p in Alzheimer's Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral Atrophy.
    Chia SY, Vipin A, Ng KP, Tu H, Bommakanti A, Wang BZ, Tan YJ, Zailan FZ, Ng ASL, Ling SC, Okamura K, Tan EK, Kandiah N, Zeng L.
    J Alzheimers Dis; 2022 Apr 15; 88(4):1567-1584. PubMed ID: 35811521
    [Abstract] [Full Text] [Related]

  • 25. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer.
    Yan S, Han B, Gao S, Wang X, Wang Z, Wang F, Zhang J, Xu D, Sun B.
    Oncotarget; 2017 Sep 01; 8(36):60149-60158. PubMed ID: 28947960
    [Abstract] [Full Text] [Related]

  • 26. Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer's Disease and Frontotemporal Dementia.
    Tan YJ, Wong BYX, Vaidyanathan R, Sreejith S, Chia SY, Kandiah N, Ng ASL, Zeng L.
    J Alzheimers Dis Rep; 2021 Sep 01; 5(1):805-813. PubMed ID: 34870106
    [Abstract] [Full Text] [Related]

  • 27. Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes.
    Yagi Y, Ohkubo T, Kawaji H, Machida A, Miyata H, Goda S, Roy S, Hayashizaki Y, Suzuki H, Yokota T.
    Neurosci Lett; 2017 Jan 01; 636():48-57. PubMed ID: 27780738
    [Abstract] [Full Text] [Related]

  • 28. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, De Roeck N, Tambasco N, Stoops E, Vanderstichele H, Engelborghs S, Mollenhauer B, Calabresi P, Parnetti L.
    Alzheimers Res Ther; 2017 Jul 28; 9(1):52. PubMed ID: 28750675
    [Abstract] [Full Text] [Related]

  • 29. Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.
    Wang MJ, Yi S, Han JY, Park SY, Jang JW, Chun IK, Giau VV, Bagyinszky E, Lim KT, Kang SM, An SS, Park YH, Youn YC, Kim S.
    J Alzheimers Dis; 2016 May 06; 52(4):1403-13. PubMed ID: 27163824
    [Abstract] [Full Text] [Related]

  • 30. Hepatitis C virus direct-acting antivirals therapy impacts on extracellular vesicles microRNAs content and on their immunomodulating properties.
    Santangelo L, Bordoni V, Montaldo C, Cimini E, Zingoni A, Battistelli C, D'Offizi G, Capobianchi MR, Santoni A, Tripodi M, Agrati C.
    Liver Int; 2018 Oct 06; 38(10):1741-1750. PubMed ID: 29359389
    [Abstract] [Full Text] [Related]

  • 31. Differential Expression and Significance of Circulating microRNAs in Cerebrospinal Fluid of Acute Encephalitis Patients Infected with Japanese Encephalitis Virus.
    Goswami S, Banerjee A, Kumari B, Bandopadhyay B, Bhattacharya N, Basu N, Vrati S, Banerjee A.
    Mol Neurobiol; 2017 Mar 06; 54(2):1541-1551. PubMed ID: 26860411
    [Abstract] [Full Text] [Related]

  • 32. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
    Sørensen SS, Nygaard AB, Christensen T.
    Transl Neurodegener; 2016 Mar 06; 5():6. PubMed ID: 26981236
    [Abstract] [Full Text] [Related]

  • 33. Intra- and Inter-individual Variability of microRNA Levels in Human Cerebrospinal Fluid: Critical Implications for Biomarker Discovery.
    Yoon H, Belmonte KC, Kasten T, Bateman R, Kim J.
    Sci Rep; 2017 Oct 05; 7(1):12720. PubMed ID: 28983117
    [Abstract] [Full Text] [Related]

  • 34. Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.
    Müller M, Kuiperij HB, Versleijen AA, Chiasserini D, Farotti L, Baschieri F, Parnetti L, Struyfs H, De Roeck N, Luyckx J, Engelborghs S, Claassen JA, Verbeek MM.
    J Alzheimers Dis; 2016 Apr 16; 52(4):1321-33. PubMed ID: 27104900
    [Abstract] [Full Text] [Related]

  • 35. MicroRNAs in Salivary Exosome as Potential Biomarkers of Aging.
    Machida T, Tomofuji T, Ekuni D, Maruyama T, Yoneda T, Kawabata Y, Mizuno H, Miyai H, Kunitomo M, Morita M.
    Int J Mol Sci; 2015 Sep 07; 16(9):21294-309. PubMed ID: 26370963
    [Abstract] [Full Text] [Related]

  • 36. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
    De Felice B, Montanino C, Oliva M, Bonavita S, Di Onofrio V, Coppola C.
    Mol Neurobiol; 2020 Nov 07; 57(11):4408-4416. PubMed ID: 32737762
    [Abstract] [Full Text] [Related]

  • 37. Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls.
    Denk J, Oberhauser F, Kornhuber J, Wiltfang J, Fassbender K, Schroeter ML, Volk AE, Diehl-Schmid J, Prudlo J, Danek A, Landwehrmeyer B, Lauer M, Otto M, Jahn H, FTLDc study group.
    PLoS One; 2018 Nov 07; 13(5):e0197329. PubMed ID: 29746584
    [Abstract] [Full Text] [Related]

  • 38. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
    Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T, Tan L.
    J Alzheimers Dis; 2014 Nov 07; 40(4):1017-27. PubMed ID: 24577456
    [Abstract] [Full Text] [Related]

  • 39. Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease.
    Alexopoulos P, Roesler J, Thierjung N, Werle L, Buck D, Yakushev I, Gleixner L, Kagerbauer S, Ortner M, Grimmer T, Kübler H, Martin J, Laskaris N, Kurz A, Perneczky R.
    Eur Arch Psychiatry Clin Neurosci; 2016 Oct 07; 266(7):587-97. PubMed ID: 26253588
    [Abstract] [Full Text] [Related]

  • 40. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M, Yadav SK, Rizwan A, Singh A, Cai K, Kaura D, Wang E, Davatzikos C, Trojanowski JQ, Melhem ER, Marincola FM, Borthakur A.
    Neuroimage Clin; 2015 Oct 07; 7():598-604. PubMed ID: 25844314
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.